Below are the most recent publications written about "Dengue" by people in Profiles.
-
Adams LE, Hitchings MDT, Medina FA, Rodriguez DM, S?nchez-Gonz?lez L, Moore H, Whitehead SS, Mu?oz-Jord?n JL, Rivera-Amill V, Paz-Bailey G. Previous Dengue Infection among Children in Puerto Rico and Implications for Dengue Vaccine Implementation. Am J Trop Med Hyg. 2023 08 02; 109(2):413-419.
-
Rodriguez DM, Major CG, S?nchez-Gonz?lez L, Jones E, Delorey MJ, Alonso C, Rivera-Amill V, Paz-Bailey G, Adams LE. Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico. Vaccine. 2023 06 01; 41(24):3627-3635.
-
Young E, Yount B, Pantoja P, Henein S, Meganck RM, McBride J, Munt JE, Baric TJ, Zhu D, Scobey T, Dong S, Tse LV, Martinez MI, Burgos AG, Graham RL, White L, DeSilva A, Sariol CA, Baric RS. A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity. Nat Commun. 2023 03 13; 14(1):1371.
-
Paz-Bailey G, S?nchez-Gonz?lez L, Torres-Velasquez B, Jones ES, Perez-Padilla J, Sharp TM, Lorenzi O, Delorey M, Munoz-Jordan JL, Tomashek KM, Waterman SH, Alvarado LI, Rivera-Amill V. Predominance of Severe Plasma Leakage in Pediatric Patients With Severe Dengue in Puerto Rico. J Infect Dis. 2022 11 28; 226(11):1949-1958.
-
Wong JM, Volkman HR, Adams LE, Oliveras Garc?a C, Martinez-Qui?ones A, Perez-Padilla J, Bertr?n-Pasarell J, Sainz de la Pe?a D, Tosado-Acevedo R, Santiago GA, Mu?oz-Jord?n JL, Torres-Vel?squez BC, Lorenzi O, S?nchez-Gonz?lez L, Rivera-Amill V, Paz-Bailey G. Clinical Features of COVID-19, Dengue, and Influenza among Adults Presenting to Emergency Departments and Urgent Care Clinics-Puerto Rico, 2012-2021. Am J Trop Med Hyg. 2023 01 11; 108(1):107-114.
-
Adams LE, S?nchez-Gonz?lez L, Rodriguez DM, Ryff K, Major C, Lorenzi O, Delorey M, Medina FA, Mu?oz-Jord?n JL, Brown G, Ortiz M, Waterman SH, Rivera-Amill V, Paz-Bailey G. Risk factors for infection with chikungunya and Zika viruses in southern Puerto Rico: A community-based cross-sectional seroprevalence survey. PLoS Negl Trop Dis. 2022 06; 16(6):e0010416.
-
Munoz-Jordan J, Cardona J, Beltr?n M, Col?n C, Schiffer J, Stewart-Clark E, Zellner B, Semenova V, Li Y, Jia LT, Maniatis P, Pawloski L, Adams L, Paz-Bailey G, Rivera-Amill V, Medina F. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):375-377.
-
Medina FA, Vila F, Premkumar L, Lorenzi O, Paz-Bailey G, Alvarado LI, Rivera-Amill V, de Silva A, Waterman S, Mu?oz-Jord?n J. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission. Am J Trop Med Hyg. 2021 12 20; 106(2):585-592.
-
Chen RE, Smith BK, Errico JM, Gordon DN, Winkler ES, VanBlargan LA, Desai C, Handley SA, Dowd KA, Amaro-Carambot E, Cardosa MJ, Sariol CA, Kallas EG, S?kaly RP, Vasilakis N, Fremont DH, Whitehead SS, Pierson TC, Diamond MS. Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity. Cell Host Microbe. 2021 11 10; 29(11):1634-1648.e5.
-
Hsieh SC, Tsai WY, Tsai JJ, Stone M, Simmons G, Busch MP, Lanteri M, Stramer SL, Balmaseda A, Harris E, Wang WK. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections. J Virol. 2021 09 09; 95(19):e0061921.